Aspen Pharmacare to buy Chinese business of Sandoz for USD 100.6 million Ruchika Sharma5 Dec 2023 4:50 PM ISTAdditionally, Aspen will dispose of the commercialisation rights and related intellectual property for four anaesthetic products currently sold by...
Eli Lilly extends tender offer to acquire POINT Biopharma to 15 Dec Ruchika Sharma5 Dec 2023 2:45 PM ISTIndianapolis: Eli Lilly and Company has announced the extension of the expiration of the tender offer to acquire all of the issued and...
Roche joins race for obesity drugs with USD 2.7 billion Carmot deal Ruchika Sharma5 Dec 2023 1:30 PM ISTRoche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to...
Pradeep Chakravarty joins Alembic Pharma as Head - Global Quality Ruchika Sharma5 Dec 2023 12:27 PM ISTVadodara: Alembic Pharma has announced that Pradeep Chakravarty has joined the Company w.e.f. 4th December, 2023, as Head - Global Quality (Senior...
JnJ gets USFDA breakthrough therapy designation for TAR 200 for bladder cancer treatment Ruchika Sharma5 Dec 2023 11:27 AM ISTTAR-200 is a novel investigational targeted releasing system designed to provide sustained local release of gemcitabine into the bladder.
AstraZeneca discontinues 2 Phase III evidence trials for Lokelma Ruchika Sharma4 Dec 2023 4:00 PM ISTThe decision to discontinue the trials is not due to safety concerns and the positive benefit-risk of Lokelma does not change in the approved...
Syngene concludes acquisition of biologics manufacturing facility from Stelis Biopharma Ruchika Sharma4 Dec 2023 3:00 PM ISTBangalore: Syngene International has announced the conclusion of the acquisition of a multi-modal biologics manufacturing facility from Stelis...
Granules India subsidiary bags USFDA nod for Sildenafil for Oral Suspension Ruchika Sharma4 Dec 2023 1:30 PM ISTSildenafil for Oral Suspension is indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in...
AstraZeneca signs USD 247 million deal with Absci to design antibody for cancer: Report Ruchika Sharma4 Dec 2023 12:30 PM ISTUnited Kingdom: Anglo-Swedish drugmaker AstraZeneca has signed a deal worth up to $247 million with U.S. artificial intelligence (AI) biologics firm...
AbbVie to acquire ImmunoGen, including its flagship cancer therapy Elahere Ruchika Sharma4 Dec 2023 11:30 AM ISTNorth Chicago, Ill.: AbbVie Inc. and ImmunoGen, Inc. have announced a definitive agreement under which AbbVie will acquire ImmunoGen, and its flagship...
Bayer, CrossBay Medical to develop novel Intrauterine System Inserter Ruchika Sharma4 Dec 2023 10:00 AM ISTBerlin: Bayer and CrossBay Medical Inc., have announced a development and option to license agreement that will allow the development and...
CDSCO Panel approves Roche's PMS Study Report of Rituximab with Glucocorticoids in Wegener's Granulomatosis Dr. Divya Colin3 Dec 2023 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved a post-marketing...
